Should spouses of hepatitis B surface antigen carriers receive hepatitis vaccine? 1983

R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein

UI MeSH Term Description Entries
D008297 Male Males
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral

Related Publications

R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
May 1982, Annals of internal medicine,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
June 1988, Nursing,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
October 1984, American journal of infection control,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
January 1980, Acta haematologica Polonica,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
November 1992, Optometry and vision science : official publication of the American Academy of Optometry,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
September 1993, Annals of internal medicine,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
July 2020, Journal of clinical gastroenterology,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
April 1995, The Pediatric infectious disease journal,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
May 2003, Journal of viral hepatitis,
R P Perrillo, and C Campbell, and G Sanders, and C Bodicky, and F Repenstein
October 2001, Cleveland Clinic journal of medicine,
Copied contents to your clipboard!